Werkzaamheid en bijwerkingen van hormonale anticonceptie


1. Bloemenkamp KW, et al. Enhancement by factor V Leiden mutation risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593-1596. 2. Jick H, et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-1593. 3. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World health organization collaborative study of cardiovascular disease and steroid hormone contraception. Lancet 1995; 346: 1582-1588. 4. Tans G, et al. Avtivated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women. Br J Haematol 2003; 122: 465-470. 5. Vliet, HAAM van. Hormonal contraceptives. Effectiveness and adverse effects [proefschrift]. Leiden: Universiteit Leiden, 2010.

Auteurs

  • mw dr A. van Hylckama Vlieg